Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report Farhat Nasim29 July 2025 4:39 PMNew Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...
Dr Reddy's Labs plans to roll out cheaper Wegovy copycat across 87 countries in 2026: CEO Ruchika Sharma25 July 2025 11:00 AMHyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an affordable copycat version...
Once-Weekly Semaglutide-Insulin Combo Matches Daily Basal-Bolus in Type 2 Diabetes Control: Study Dr Riya Dave25 July 2025 4:00 AMAccording to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and insulin icodec was...
Consuming more protein may protect patients taking anti-obesity drug from muscle loss: Study Dr. Kamal Kant Kohli24 July 2025 3:00 PMWomen and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent...
Anti-obesity medications associated with weight rebound post-treatment,suggests study Dr. Kamal Kant Kohli23 July 2025 3:30 AMPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis...
Weight Returns for Many After Stopping Anti-Obesity Drugs: Meta-Analysis Dr. Bhumika Maikhuri23 July 2025 2:30 AMPatients who take anti-obesity medications to aid in weight loss may experience significant weight regain after stopping the drugs, according to a new...
Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study Medha Baranwal19 July 2025 3:45 AMTaiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and...
GLP-1 RAs Lower Risk of Liver Damage and Death in Alcohol Use, reveals research Dr Riya Dave14 July 2025 3:45 AMResearchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of alcohol-related liver...
Tirzepatide Shakes Up Obesity Market as Mounjaro Records Rs 390 Mn Sales in June Farhat Nasim11 July 2025 9:35 AMNew Delhi: In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is quickly...
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss Dr. Kamal Kant Kohli9 July 2025 3:30 PMSleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists...
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment Wegovy Ruchika Sharma9 July 2025 6:06 AMDenmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has announced the...
Medical Bulletin 04/Jul/2025 Dr. Bhumika Maikhuri4 July 2025 9:30 AMHere are the top medical news for the day:WHO Issues Safety Over Rare Eye Disorder from Semaglutide UseWHO is alerting health-care professionals and...
